Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth-Reference-Cited by-同舟云学术

Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth

Published:2025-02 Issue: Volume:112 Page:105544
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Pollock Katrina M.,Cheeseman Hannah M.^ORCID,McFarlane Leon R.,Day Suzanne,Tolazzi Monica,Turner Hannah L.^ORCID,Joypooranachandran Jennifer^ORCID,Shramko Katsiaryna,Dispinseri Stefania,Mundsperger Philipp,Bontjer Ilja,Lemm Nana-Marie,Coelho Sofia^ORCID,Tanaka Maniola,Cole Tom,Korber Bette,Katinger Dietmar,Sattentau Quentin J.,Ward Andrew B.,Scarlatti Gabriella,Sanders Rogier W.,Shattock Robin J.^ORCID

Publisher

Elsevier BV

Reference57 articles.

1. Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: a first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial;Houser;EClinicalMedicine,2022

2. Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1;Kwong;Cold Spring Harb Perspect Med,2011

3. Envelope glycoprotein trimers as HIV-1 vaccine immunogens;Sattentau;Vaccines (Basel),2013

4. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection;Gray;J Virol,2011

5. Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection;Hraber;AIDS,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles;2025-05-05